(CVE)
0.00
0.00 (0.00%)
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
0.00
0.00 (0.00%)
This stock has a consensus price target of $30.57 based on the ratings of 7 analysts. The high is $34.00 and the low is $28.00.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 28 | $ 30.57 | $ 34 |
| O’zgarish | 4.40% | 13.98% | 26.77% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-03-12 | 8.13% | Goldman Sachs | $22 → $29 | Maintains | Buy |
| 2026-02-20 | 19.31% | RBC Capital | $31 → $32 | Maintains | Outperform |
| 2026-02-18 | 15.59% | RBC Capital | $29 → $31 | Maintains | Outperform |
| 2026-01-02 | -25.43% | Goldman Sachs | $20 | Reinstates | Buy |
| 2025-11-17 | 19.31% | RBC Capital | $30 → $32 | Maintains | Outperform |